Teva Pharma - מכפיל P/S עתידי TEVA

Teva Pharmaceutical Industries Ltd. (TEVA) - לוגו תאגידי

The shift toward innovative biosimilars and cost restructuring is currently defining the market trajectory for Teva Pharmaceutical Industries (TEVA). The company's forward P/S reflects current price momentum, where a metric value of 0.40 confirms the trend's sustainability. This is based on its global status as a generics leader and its proprietary API logistics, which transforms mass-market medications into a reliable cash cow.

TEVA (Teva) היסטוריית יחס מחיר להכנסות צפויות מ-04.07.2022 עד 18.11.2026

Teva Pharmaceutical Industries (TEVA) - פילוחי מדדים ודוחות פיננסיים

- מחיר שוק ויעדי מחיר של אנליסטים:
ניתוח פונדמנטלי של החברה:Teva Pharmaceuticals (TEVA)
מוצרים מיוצרים של Teva Pharmaceutical Industries Ltd.

The forward P/S reflects market capitalization relative to projected annual revenue, measuring investor confidence in future cash flows. By analyzing the forward P/S of a business, one can assess the extent to which the market is willing to award the company a premium for its operational efficiency and resilience. For Teva Pharmaceutical Industries (TEVA), this multiple accounts for capital expenditures on the environmental modernization of generic production facilities, which impact the final asset value.